Steviol, a natural product inhibits proliferation of the gastrointestinal cancer cells intensively

Oncotarget

Volumn 9, Issue 41, 2018, Pages 26299-26308

  Chen, Junming ^a   Xia, Yongmei ^a   Sui, Xiaochen ^a   Peng, Qingrui ^a   Zhang, Tongtong ^a   Li, Jian ^b   Zhang, Jue ^b  

^a JIANGNAN UNIVERSITY   (China)

^b JIANGSU INSTITUTE OF NUCLEAR MEDICINE   (China)

Author keywords

Cancer; Gastrointestinal; Steviol; Steviol glycoside

Indexed keywords

CASPASE 3; FLUOROURACIL; METFORMIN; MICRORNA 1268B; MICRORNA 203A 3P; MICRORNA 23C; MICRORNA 6088; OXALIPLATIN; PROTEIN BAX; PROTEIN BCL 2; PROTEIN P21; PROTEIN P53; SORAFENIB; STEVIOL; UNCLASSIFIED DRUG;

ANTINEOPLASTIC ACTIVITY; APOPTOSIS; ARTICLE; CANCER CELL LINE; CANCER CHEMOTHERAPY; CANCER INHIBITION; CONTROLLED STUDY; DIGESTIVE SYSTEM CANCER; DRUG CYTOTOXICITY; HCT 116 CELL LINE; HUMAN; HUMAN CELL; MITOCHONDRION; MKN45 CELL LINE; REGULATORY MECHANISM; RNA ANALYSIS;

EID: 85047625336     PISSN: None     EISSN: 19492553     Source Type: Journal    
DOI: 10.18632/oncotarget.25233     Document Type: Article

References (38)

1. Chen W, Zheng R, Baade PD, Zhang S, Zeng H, Bray F, Jemal A, Yu XQ, He J. Cancer statistics in China, 2015. CA Cancer J Clin. 2016; 66:115-32. https://doi.org/10.3322/ caac.21338
2. Zhong BL, Li SH, Lv SY, Tian SL, Liu ZD, Li XB, Zhuang HQ, Tao R, Zhang W, Zhuo CJ. Suicidal ideation among Chinese cancer inpatients of general hospitals: prevalence and correlates. Oncotarget. 2017; 8:25141-25150. https:// doi.org/10.18632/oncotarget.15350
3. Wang M, Lu J, Li J, Qi H, Wang Y, Zhang H. Steviol glucuronidation and its potential interaction with UDPglucuronosyltransferase 2B7 substrates. Food Chem Toxicol. 2014; 64:135-43. https://doi.org/10.1016/j. fct.2013.11.028
4. Renwick AG, Tarka SM. Microbial hydrolysis of steviol glycosides. Food Chem Toxicol. 2008; 46:S70-74. https:// doi.org/10.1016/j.fct.2008.05.008
5. Purkayastha S, Pugh G Jr, Lynch B, Roberts A, Kwok D, Tarka SM Jr. In vitro metabolism of rebaudioside B, D, and M under anaerobic conditions: comparison with rebaudioside A. Regul Toxicol Pharmacol. 2014; 68:259-68 https://doi.org/10.1016/j.yrtph.2013.12.004
6. Chen J, Wang X, Xia Y, Zhang J, Li J. The natural sweetener metabolite steviol inhibits human osteosarcoma cell line U2OS. Oncol Lett. 2018; 15:5250-5256
7. Toskulkao C, Chaturat L, Temcharoen P, Glinsukon T. Acute toxicity of stevioside, a natural sweetener, and its metabolite, steviol, in several animal species. Drug Chem Toxicol. 1997; 20:31-44. https://doi. org/10.3109/01480549709011077
8. EFSA ANS Panel (EFSA Panel on Food Additives and Nutrient Sources added to Food). Scientific Opinion on the safety of steviol glycosides for the proposed uses as a food additive. EFSA J. 2010; 8:1537. https://doi.org/10.2903/j. efsa.2010.1537
9. Yoshikawa R, Kusunoki M, Yanagi H, Noda M, Furuyama JI, Yamamura T, Hashimoto-Tamaoki T. Dual antitumor effects of 5-fluorouracil on the cell cycle in colorectal carcinoma cells: a novel target mechanism concept for pharmacokinetic modulating chemotherapy. Cancer Res. 2001; 61:1029-37
10. Osaki M, Tatebe S, Goto A, Hayashi H, Oshimura M, Ito H. 5-Fluorouracil (5-FU) induced apoptosis in gastric cancer cell lines: role of the p53 gene. Apoptosis. 1997; 2:221-26. https://doi.org/10.1023/A:1026476801463
11. Li J, Hou N, Faried A, Tsutsumi S, Takeuchi T, Kuwano H. Inhibition of autophagy by 3-MA enhances the effect of 5-FU-induced apoptosis in colon cancer cells. Ann Surg Oncol. 2009; 16:761-71. https://doi.org/10.1245/ s10434-008-0260-0
12. Qin LF, Ng IO. Induction of apoptosis by cisplatin and its effect on cell cycle-related proteins and cell cycle changes in hepatoma cells. Cancer Lett. 2002; 175:27-38. https:// doi.org/10.1016/S0304-3835(01)00720-0
13. Zinkel S, Gross A, Yang E. BCL2 family in DNA damage and cell cycle control. Cell Death Differ. 2006; 13:1351-59. https://doi.org/10.1038/sj.cdd.4401987
14. Murakami Y, Kawada N. MicroRNAs in hepatic pathophysiology. Hepatol Res. 2017; 47:60-69. https://doi. org/10.1111/hepr.12730
15. Amirkhah R, Schmitz U, Linnebacher M, Wolkenhauer O, Farazmand A. MicroRNA-mRNA interactions in colorectal cancer and their role in tumor progression. Genes Chromosomes Cancer. 2015; 54:129-41. https://doi. org/10.1002/gcc.22231
16. Xiao J, Lv D, Zhou J, Bei Y, Chen T, Hu M, Zhou Q, Fu S, Huang Q. Therapeutic Inhibition of miR-4260 Suppresses Colorectal Cancer via Targeting MCC and SMAD4. Theranostics. 2017; 7:1901-13. https://doi.org/10.7150/ thno.19168
17. Tessitore A, Cicciarelli G, Mastroiaco V, Vecchio FD, Capece D, Verzella D, Fischietti M, Vecchiotti D, Zazzeroni F, Alesse E. Therapeutic Use of MicroRNAs in Cancer. Anticancer Agents Med Chem. 2016; 16:7-19. https://doi. org/10.2174/1871520615666150824153358
18. Lewis BP, Burge CB, Bartel DP. Conserved seed pairing, often flanked by adenosines, indicates that thousands of human genes are microRNA targets. Cell. 2005; 120:15-20. https://doi.org/10.1016/j.cell.2004.12.035
19. Grimson A, Farh KK, Johnston WK, Garrett-Engele P, Lim LP, Bartel DP. MicroRNA targeting specificity in mammals: determinants beyond seed pairing. Mol Cell. 2007; 27:91-105 https://doi.org/10.1016/j.molcel.2007.06.017
20. Friedman RC, Farh KK, Burge CB, Bartel DP. Most mammalian mRNAs are conserved targets of microRNAs. Genome Res. 2009; 19:92-105. https://doi.org/10.1101/ gr.082701.108
21. Garcia DM, Baek D, Shin C, Bell GW, Grimson A, Bartel DP. Weak seed-pairing stability and high target-site abundance decrease the proficiency of lsy-6 and other microRNAs. Nat Struct Mol Biol. 2011; 18:1139-46. https://doi.org/10.1038/nsmb.2115
22. Agarwal V, Bell GW, Nam JW, Bartel DP. Predicting effective microRNA target sites in mammalian mRNAs. elife. 2015; 4:e05005
23. Xu B, Huang Y, Niu X, Tao T, Jiang L, Tong N, Chen S, Liu N, Zhu W, Chen M. Hsa-miR-146a-5p modulates androgen-independent prostate cancer cells apoptosis by targeting ROCK1. Prostate. 2015; 75:1896-903. https://doi. org/10.1002/pros.23068
24. Wolter M, Werner T, Malzkorn B, Reifenberger G. Role of microRNAs Located on Chromosome Arm 10q in Malignant Gliomas. Brain Pathol. 2016; 26:344-58. https:// doi.org/10.1111/bpa.12294
25. Kara M, Yumrutas O, Ozcan O, Celik OI, Bozgeyik E, Bozgeyik I, Tasdemir S. Differential expressions of cancer-associated genes and their regulatory miRNAs in colorectal carcinoma. Gene. 2015; 567:81-86. https://doi. org/10.1016/j.gene.2015.04.065
26. Lopes-Ramos CM, Habr-Gama A, Quevedo BS, Felício NM, Bettoni F, Koyama FC, Asprino PF, Galante PA, Gama-Rodrigues J, Camargo AA, Perez RO, Parmigiani RB. Overexpression of miR-21-5p as a predictive marker for complete tumor regression to neoadjuvant chemoradiotherapy in rectal cancer patients. BMC Med Genomics. 2014; 7:68. https://doi.org/10.1186/ s12920-014-0068-7
27. Cheng J, Chen Y, Zhao P, Liu X, Dong J, Li J, Huang C, Wu R, Lv Y. Downregulation of miRNA-638 promotes angiogenesis and growth of hepatocellular carcinoma by targeting VEGF. Oncotarget. 2016; 7:30702-30711. https:// doi.org/10.18632/oncotarget.8930
28. Hibino S, Saito Y, Muramatsu T, Otani A, Kasai Y, Kimura M, Saito H. Inhibitors of enhancer of zeste homolog 2 (EZH2) activate tumor-suppressor microRNAs in human cancer cells. Oncogenesis. 2014; 3:e104. https://doi. org/10.1038/oncsis.2014.17
29. Kuroda K, Fukuda T, Krstic-Demonacos M, Demonacos C, Okumura K, Isogai H, Hayashi M, Saito K, Isogai E. miR-663a regulates growth of colon cancer cells, after administration of antimicrobial peptides, by targeting CXCR4-p21 pathway. BMC Cancer. 2017; 17:33. https:// doi.org/10.1186/s12885-016-3003-9
30. Bandiera S, Pernot S, El Saghire H, Durand SC, Thumann C, Crouchet E, Ye T, Fofana I, Oudot MA, Barths J, Schuster C, Pessaux P, Heim MH, et al. Hepatitis C virus-induced upregulation of microRNA miR-146a-5p in hepatocytes promotes viral infection and deregulates metabolic pathways associated with liver disease pathogenesis. J Virol. 2016; 90:6387-400. https://doi. org/10.1128/JVI.00619-16
31. Chen Z, Wang X, Liu R, Chen L, Yi J, Qi B, Shuang Z, Liu M, Li X, Li S, Tang H. KDM4B-mediated epigenetic silencing of miRNA-615-5p augments RAB24 to facilitate malignancy of hepatoma cells. Oncotarget. 2017; 8:17712-17725 https://doi.org/10.18632/oncotarget.10832
32. Slattery ML, Herrick JS, Mullany LE, Wolff E, Hoffman MD, Pellatt DF, Stevens JR, Wolff RK. Colorectal tumor molecular phenotype and miRNA: expression profiles and prognosis. Mod Pathol. 2016; 29:915-27. https://doi. org/10.1038/modpathol.2016.73
33. Tan S, Shi H, Ba M, Lin S, Tang H, Zeng X, Zhang X. miR-409-3p sensitizes colon cancer cells to oxaliplatin by inhibiting Beclin-1-mediated autophagy. Int J Mol Med. 2016; 37:1030-38. https://doi.org/10.3892/ijmm.2016.2492
34. Pehserl AM, Ress AL, Stanzer S, Resel M, Karbiener M, Stadelmeyer E, Stiegelbauer V, Gerger A, Mayr C, Scheideler M, Hutterer GC, Bauernhofer T, Kiesslich T, Pichler M. Comprehensive analysis of miRNome alterations in response to sorafenib treatment in colorectal cancer cells. Int J Mol Sci. 2016; 17:2011. https://doi.org/10.3390/ ijms17122011
35. Yang Y, Ma ZH, Li XG, Zhang WF, Wan J, Du LJ, Li GJ, Yang GK, Lu P. Iodine-125 irradiation inhibits invasion of gastric cancer cells by reactivating microRNA-181c expression. Oncol Lett. 2016; 12:2789-95. https://doi. org/10.3892/ol.2016.5033
36. Kato K, Gong J, Iwama H, Kitanaka A, Tani J, Miyoshi H, Nomura K, Mimura S, Kobayashi M, Aritomo Y, Kobara H, Mori H, Himoto T, et al. The antidiabetic drug metformin inhibits gastric cancer cell proliferation in vitro and in vivo. Mol Cancer Ther. 2012; 11:549-60. https://doi. org/10.1158/1535-7163.MCT-11-0594
37. Shen J, Park HS, Xia YM, Kim GS, Cui SW. The polysaccharides from fermented Ganoderma lucidum mycelia induced miRNAs regulation in suppressed HepG2 cells. Carbohydr Polym. 2014; 103:319-24. https://doi. org/10.1016/j.carbpol.2013.12.044
38. Plumb JA. Cell sensitivity assays: the MTT assay. Methods Mol Med. 2004; 88:165-69